Adult patients hospitalised with MRSA bacteraemia will be randomly assigned ( 1:1 ) to group 1 : daptomycin 10mg/kg/24h intravenous ; or group 2 : daptomycin 10mg/kg/24h intravenous plus fosfomycin 2gr/6g intravenous .